BlueWind Medical
Herzliya, Israel· Est.
BlueWind Medical commercial an implantable tibial neuromodulation device (Revi) for drug‑free treatment of urge urinary incontinence.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
BlueWind Medical commercial an implantable tibial neuromodulation device (Revi) for drug‑free treatment of urge urinary incontinence.
UrologyOveractive Bladder
Technology Platform
Implantable tibial neuromodulation (iTNM) delivering programmable electrical stimulation via a miniature ankle‑mounted device.
Opportunities
Reimbursement expansion and international market rollout of Revi, plus potential application of the iTNM platform to other lower urinary tract disorders.
Risk Factors
Strong competition from sacral neuromodulation and percutaneous tibial stimulation, regulatory hurdles in new regions, and need for sustained capital to scale commercial operations.
Competitive Landscape
Key competitors include Medtronic’s InterStim (sacral neuromodulation) and percutaneous tibial nerve stimulation systems; Revi differentiates through a fully implantable, patient‑controlled design that reduces procedural burden and improves adherence.